GEMCITABINE (GEM) AND CISPLATIN (CIS) IS AN ACTIVE REGIMEN FOR ADVANCED TRANSITIONAL-CELL CARCINOMA (TCC) - RESULTS OF A PHASE-II STUDY

Authors
MOORE M TANNOCK I WINQUIST E TOLCHER A BENNETT K SEYMOUR L
Citation
M. Moore et al., GEMCITABINE (GEM) AND CISPLATIN (CIS) IS AN ACTIVE REGIMEN FOR ADVANCED TRANSITIONAL-CELL CARCINOMA (TCC) - RESULTS OF A PHASE-II STUDY, Annals of oncology, 9, 1998, pp. 646-646
Citations number
NO
Categorie Soggetti
Oncology
Journal title
Annals of oncology → ACNP
ISSN journal
09237534
Volume
9
Year of publication
1998
Supplement
2
Pages
646 - 646
Database
ISI
SICI code
0923-7534(1998)9:<646:G(AC(I>2.0.ZU;2-L